Cell Lysis Dissociation Market Size is projected to reach USD 10.56 Billion by 2032, growing at A CAGR of 9%

Market Overview: In 2022, the global cell lysis dissociation market had a valuation of USD 4.86 billion, with a projected revenue compound annual growth rate (CAGR) of 9% for the forecast period. Key drivers of market growth include the increasing demand for cell-based assays in research and development, the growing prevalence of chronic and infectious diseases, and advancements in cell lysis and dissociation technology.

Cell lysis and dissociation products find extensive applications, including protein isolation, gene expression studies, and drug development. Furthermore, the biotechnology and pharmaceutical industries are witnessing increased investments, which contribute to the rising demand for these products.

The market is expected to experience heightened demand due to the expanding interest in personalized medicine and regenerative medicine. Cell lysis and dissociation play crucial roles in personalized medicine by enabling the examination of a patient's genetic profile for tailored treatment options. Additionally, the materials resulting from these processes are used in creating cell-based therapeutics and regenerative medicine products. The prevalence of chronic and infectious diseases, including cancer, Alzheimer's disease, and diabetes, also fuels the demand for cell-based assays.

Get a sample copy of the Chromium Market report: https://www.reportsanddata.com/download-free-sample/6045

Key Insights: Product Categories: The global cell lysis dissociation market is categorized into mechanical disruption, chemical disruption, enzymatic digestion, and other product segments. Mechanical disruption, which includes techniques such as sonication, grinding, and homogenization, is expected to dominate the market during the forecast period due to its high efficacy in cell lysis and dissociation. Mechanical disruption excels at producing homogenized cells while preserving their biological activity. The rising utilization of mechanical disruption in various industries, including biotechnology, medical research, and life sciences, is a significant driver of this segment's revenue growth.

The chemical disruption segment is projected to exhibit the fastest revenue CAGR. This method employs various chemicals, including detergents, chaotropic substances, and enzymes, to disrupt cell membranes and release cellular contents. Chemical disruption is particularly valuable for materials that are difficult to mechanically disrupt, such as tissues rich in collagen or extracellular matrix. Increased application of chemical lysis in drug discovery and development, proteomics, and genomics studies is expected to fuel revenue growth in this segment.

End-Use Categories: The cell lysis dissociation market's end-use segments encompass research laboratories, biopharmaceutical companies, contract research organizations (CROs), and others. Biopharmaceutical companies are poised to hold the largest share of revenue during the forecast period, driven by the growing need for cell lysis and dissociation procedures in drug research and development. These techniques are pivotal in biopharmaceutical research as they facilitate the isolation and purification of specific cell populations for further study. With the increased focus on personalized medicine, more biopharmaceutical firms are expected to enter the market.

CROs are projected to experience the swiftest revenue CAGR. These organizations provide specialized services to the pharmaceutical, biotechnology, and medical device sectors, offering support in preclinical and clinical research, drug discovery, and drug development. The outsourcing of research-related tasks by pharmaceutical and biotechnology companies is a key factor contributing to the growth of the CRO segment.

Regional Insights: North America is expected to account for the largest share of revenue in the cell lysis dissociation market during the forecast period. The region's demand for products facilitating cell lysis and dissociation is driven by the increasing use of cell-based assays in drug development and research, as well as substantial funding for proteomics and genomics studies. Established biotech and pharmaceutical companies in North America are also likely to contribute to market revenue growth.

Asia Pacific is anticipated to register the highest revenue CAGR in the forecast period, primarily due to the rising prevalence of chronic diseases in countries like China and India, increased government initiatives and funding for cell-based therapeutics research and development, and the accessibility of cost-effective cell lysis and dissociation products. The region's adoption of cell-based assays and the presence of affordable cell lysis and dissociation products will further drive revenue growth.

Europe is projected to hold the second-largest revenue share in the market. The region's revenue growth will be fueled by the increasing prevalence of chronic diseases and rising investment in research and development activities, as well as the presence of established biotech and pharmaceutical firms.

Competitive Landscape: Key players in the cell lysis dissociation market include Thermo Fisher Scientific Inc., Merck KGaA, QIAGEN N.V., Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Miltenyi Biotec, F. Hoffmann-La Roche Ltd., Danaher Corporation, Promega Corporation, and Lonza Group. These companies engage in strategic developments to strengthen their positions in the market. For instance:

1.      Thermo Fisher Scientific Inc. acquired PPD, Inc. on December 8, 2021, for approximately USD 17.4 billion, enhancing its presence in the life sciences market.

2.      On April 9, 2020, Bio-Rad Laboratories, Inc. acquired Celsee, Inc., expanding its product offerings in the single-cell analysis market.

3.      Becton, Dickinson and Company acquired Straub Medical AG on June 1, 2020, to extend its product offerings in the vascular access market.

Report Scope: The report provides historical data and forecasts revenue growth globally, regionally, and at the country level, analyzing market trends in various segments and sub-segments from 2019 to 2032. The global cell lysis dissociation market is segmented based on product, end-use, and region. The report covers parameters like market size in 2022, revenue forecast for 2032, CAGR, and offers a detailed analysis of product and end-use segments, regional insights, and profiles of key companies. Customization options and expert consultation are also available.

Explore Trending Reports:

Veterinary Imaging Market-https://www.globenewswire.com/news-release/2020/09/03/2088830/0/en/Veterinary-Imaging-Market-To-Reach-USD-2-72-Billion-By-2027-Reports-and-Data.html

Animal Health Market-https://www.globenewswire.com/news-release/2019/05/07/1818679/0/en/Global-Animal-Health-Market-To-Reach-USD-70-01-Billion-By-2026-Reports-And-Data.html

Digital Pathology Market-https://www.globenewswire.com/news-release/2019/06/10/1866406/0/en/Digital-Pathology-Market-To-Reach-USD-1180-2-Million-By-2026-Reports-And-Data.html

Hemodynamic Monitoring Devices Market-https://www.globenewswire.com/news-release/2019/10/24/1935193/0/en/Hemodynamic-Monitoring-Devices-Market-To-Reach-USD-1-39-Billion-By-2026-Reports-And-Data.html

Request a customization of the report: https://www.reportsanddata.com/request-customization-form/6045

Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.

About Reports and Data    

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report

Browse Latest Blogs: https://www.reportsanddata.com/blogs

Browse Latest Press Release: https://www.reportsanddata.com/press-release

Comments

Post a Comment

Popular posts from this blog

Aprotic Solvents Market Analysis by Size, Share, Growth, Trends, 2028

Market Overview: In 2020, the global market for aprotic solvents experienced significant revenue growth and is projected to maintain a double-digit revenue compound annual growth rate (CAGR) throughout the forecast period. Key drivers of this growth include the unique characteristics of aprotic solvents, such as high polarity, dipole moment, dielectric constant, low skin penetration, and stability in acidic conditions. Additionally, the rising utilization of aprotic solvents in various industries, including agriculture, pharmaceuticals, and electronics, both as reaction solvents and cleaning agents, is expected to further propel market revenue growth. Among the application segments, the oil & gas industry is anticipated to exhibit the highest revenue CAGR, followed by the pharmaceutical segment. Particularly, the continued use of N-Methyl-2-pyrrolidone solvent for various applications in the oil and gas sector is poised to drive market expansion. Get a sample copy of the Aproti...
Read more

Stroke Treatment Market Emerging Trends, Demand, Growth by Key Players and Forecast 2028

Market Overview: The global market for stroke treatment demonstrated significant strength in 2020 and is anticipated to experience a rapidly increasing revenue compound annual growth rate (CAGR) throughout the forecast period. The rise in the prevalence of chronic illnesses among the growing geriatric population is expected to drive the growth of market revenue. Additionally, the vulnerability of older individuals to strokes, coupled with the escalating consumption of tobacco and the increasing incidence of diabetes, is poised to further boost market growth in the near future. Companies Profiled in the Report: Key companies in the global market include Sanofi, Daiichi Sankyo Company, Limited., Johnson & Johnson Services, Inc., Amgen Inc., Boehringer Ingelheim GmbH, AstraZeneca, F. Hoffmann-La Roche (Genentech), Bristol-Myers Squibb Company, and Biogen Inc. These key players are investing significantly in technological advancements, production capacity, and strategic alliances su...
Read more

Companion Animal Postoperative Pain Management Therapeutics Market to Expand at A CAGR of 6.5%by 2032

Market Overview: The global market for therapeutics addressing postoperative pain in companion animals attained a value of USD 681.81 million in 2022 and is poised to achieve USD 1.20 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.5% throughout the forecast period. Key drivers propelling revenue expansion include the escalating adoption of companion animals, increased prevalence of surgical procedures among these animals, and heightened awareness among pet owners regarding the significance of pain management in animals. The surge in companion animal adoption worldwide stands out as a pivotal factor fueling the revenue growth of the companion animal postoperative pain management therapeutics market. Notably, the adoption of pets like dogs, cats, and horses has surged, leading to a notable uptick in surgical interventions for these animals and subsequently, a heightened demand for postoperative pain management therapeutics. Get a sample copy of the Companion ...
Read more